[ Price : $8.95]
FDA approves Alexion Pharmaceuticals Ultomiris (ravulizumab-cwvz) 100 mg/mL, a new dosing formulation for treating adults with par...[ Price : $8.95]
FDA clears a GE Healthcare 510(k) for the Ultra Edition package on its Vivid cardiovascular ultrasound systems, which includes new...[ Price : $8.95]
FDA accepts for review a Foresee Pharmaceuticals 505(b)(2) NDA for Camcevi 42mg, a ready-to-use six-month depot formulation of leu...[ Price : $8.95]
FDA grants Beckman Coulter an emergency use authorization for its Access SARS-CoV-2 Immunoglobulin M (IgM) assay.[ Price : $8.95]
FDA issues a revised Manual of Policies and Procedures on ANDA Suitability Petitions to clarify certain issues and include minor u...[ Price : $8.95]
Federal Register notice: FDA withdraws approval of 13 NDAs from multiple applicants after they notified the agency that the drug p...[ Price : $8.95]
Federal Register notice: FDA withdraws approval of nine ANDAs from multiple applicants after they notified the agency that the dru...[ Price : $8.95]
FDA tells Intercept Pharmaceuticals that it is evaluating a newly identified safety signal regarding liver disorder for Ocaliva.